ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Mereo BioPharma Group PLC

Mereo BioPharma Group PLC (MREO)

2.93
0.06
(2.09%)
終了 1月30日 6:00AM
2.94
0.01
(0.34%)
取引時間後: 9:59AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
2.93
買値
2.90
売値
3.33
出来高
721,529
2.8425 日の範囲 3.02
2.525 52 週間の範囲 5.02
時価総額
前日終値
2.87
始値
2.85
最終取引時間
財務取引量
US$ 2,105,163
VWAP
2.9176
平均取引量 (3 か月)
1,073,133
発行済株式数
155,145,607
配当利回り
-
PER
-13.74
1 株当たり利益 (EPS)
-0.21
歳入
8.04M
純利益
-33.18M

Mereo BioPharma Group PLC について

Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with ad... Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of innovative therapeutics that aim to improve outcomes for oncology and rare diseases. Its lead oncology product candidate is etigilimab, for patients with advanced solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
London, Gbr
設立
-
Mereo BioPharma Group PLC is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker MREO. The last closing price for Mereo BioPharma was US$2.87. Over the last year, Mereo BioPharma shares have traded in a share price range of US$ 2.525 to US$ 5.02.

Mereo BioPharma currently has 155,145,607 shares in issue. The market capitalisation of Mereo BioPharma is US$445.27 million. Mereo BioPharma has a price to earnings ratio (PE ratio) of -13.74.

MREO 最新ニュース

Mereo BioPharma Provides Update on Lead Clinical Programs

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025 Alvelestat, for Alpha-1 Antitrypsin Deficiency-associated Lung...

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

LONDON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.09-2.980132450333.023.142.81512874832.91086997CS
4-0.52-15.07246376813.453.832.813796873.20232373CS
12-1.22-29.39759036144.154.3952.810731333.45111396CS
26-1.24-29.73621103124.175.022.89148713.84297132CS
52-1.01-25.63451776653.945.022.52510470323.68150303CS
1561.73144.1666666671.25.020.30114325231.93744496CS
2601.1766.47727272731.765.020.30112779192.33252819CS

MREO - Frequently Asked Questions (FAQ)

What is the current Mereo BioPharma share price?
The current share price of Mereo BioPharma is US$ 2.93
How many Mereo BioPharma shares are in issue?
Mereo BioPharma has 155,145,607 shares in issue
What is the market cap of Mereo BioPharma?
The market capitalisation of Mereo BioPharma is USD 445.27M
What is the 1 year trading range for Mereo BioPharma share price?
Mereo BioPharma has traded in the range of US$ 2.525 to US$ 5.02 during the past year
What is the PE ratio of Mereo BioPharma?
The price to earnings ratio of Mereo BioPharma is -13.74
What is the cash to sales ratio of Mereo BioPharma?
The cash to sales ratio of Mereo BioPharma is 56.76
What is the reporting currency for Mereo BioPharma?
Mereo BioPharma reports financial results in GBP
What is the latest annual turnover for Mereo BioPharma?
The latest annual turnover of Mereo BioPharma is GBP 8.04M
What is the latest annual profit for Mereo BioPharma?
The latest annual profit of Mereo BioPharma is GBP -33.18M
What is the registered address of Mereo BioPharma?
The registered address for Mereo BioPharma is FOURTH FLOOR, ONE CAVENDISH PLACE, LONDON, W1G 0QF
What is the Mereo BioPharma website address?
The website address for Mereo BioPharma is www.mereobiopharma.com
Which industry sector does Mereo BioPharma operate in?
Mereo BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
DGNXDiginex Ltd
US$ 49.18
(228.09%)
3.34M
SLXNSilexion Therapeutics Corporation
US$ 3.1301
(131.86%)
330.45M
KRKR36Kr Holdings Inc
US$ 9.10
(114.12%)
23.61M
SPGCSacks Parente Golf Inc
US$ 0.6001
(57.92%)
52.17M
XFORX4 Pharmaceuticals Inc
US$ 0.7542
(56.54%)
42.5M
ZKINZK International Group Co Ltd
US$ 0.4813
(-41.21%)
3.1M
MGOLMGO Global Inc
US$ 0.1019
(-38.73%)
70.52M
BACKIMAC Holdings Inc
US$ 0.7869
(-35.50%)
2.37M
EYENEyenovia Inc
US$ 0.03695
(-35.18%)
25.31M
HAOHaoxi Health Technology Ltd
US$ 2.52
(-31.89%)
484.94k
NVDANVIDIA Corporation
US$ 123.70
(-4.10%)
466.94M
SLXNSilexion Therapeutics Corporation
US$ 3.1301
(131.86%)
330.45M
OCEAOcean Biomedical Inc
US$ 0.249929
(-24.26%)
186.52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.428
(-6.98%)
148.12M
RIMEAlgorhythm Holdings Inc
US$ 0.0259
(-16.18%)
138.96M

MREO Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock